Sequencing Questions Remain in Prostate Cancer Paradigm
Christopher Sweeney, MBBS, discusses the role of abiraterone for patients with hormone-sensitive prostate cancer, and what physicians should consider when choosing between abiraterone and docetaxel.
Source: OncLive